Clinical trial
Phase 2 Randomized, Multicenter, Safety and Efficacy Trial to Evaluate Different Oral Benznidazole Monotherapy and Benznidazole/E1224 Combination Regimens for the Treatment of Adult Patients With Chronic Indeterminate Chagas Disease
NCT03378661 is registered in ClinicalTrials.gov with Drugs for Neglected Diseases as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Phase 2 Randomized, Multicenter, Safety and Efficacy Trial to Evaluate Different Oral Benznidazole Monotherapy and Benznidazole/E1224 Combination Regimens for the Treatment of Adult Patients With Chronic Indeterminate Chagas Disease
- Lead sponsor
- Drugs for Neglected Diseases
- Phase
- Phase 2
- Overall status
- Unknown status
- Start date
- November 30, 2016
- Completion date
- July 27, 2018
- Enrollment
- 210 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.